最新ニュース Aon (NYSE:AON) 株価情報

Aon is a leading global provider of insurance and reinsurance brokerage and human resources solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in over 120 countries.

Aon plc Class A Ordinary Shares (Ireland)

Aon PLC

AMER ONCOLOGY NETWORK A by American Oncology Network, Inc.

American Oncology Network Inc

American Oncology Network Inc Warrants (31/03/2028)

AEON Co Ltd

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 15 years by 4.59% on an annualized basis producing an average annual return of 16.05%. Currently, Aon has a market capitalization of $76.77 billion. 
Buying $100 In AON: If an investor had bought $100 of AON stock 15 years ago, it would be worth $936.87 today based on a price of $354.98 for AON at the time of writing.
<h3>Aon's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735912809_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much $100 Invested In Aon 15 Years Ago Would Be Worth Today

JP Morgan analyst Jimmy Bhullar maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Overweight and raises the price target from $379 to $394.

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Aon, Raises Price Target to $394

Eli Lilly and Co.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Zepbound (tirzepatide) is reshaping the competitive landscape in obesity treatment, challenging Novo Nordisk A/S' (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy (semaglutide) for market dominance.
According to a GlobalData <a target="_blank" href="https://www.globaldata.com/media/pharma/eli-lillys-zepbound-holds-potential-dominate-obesity-market-says-globaldata/" rel="noreferrer noopener">report</a>, Zepbound's superior effectiveness and strategic market growth position it to potentially overtake Wegovy as the <a target="_blank" href="https://www.benzinga.com/24/12/42613036/novo-nordisks-hybrid-weight-loss-drug-falls-short-on-expectations-stock-plunges" rel="noreferrer noopener">leading therapy for obesity</a>.
Since its debut, Zepbound has expanded its scope beyond obesity treatment. In December 2024, the FDA approved the drug for treating <a target="_blank" href="https://www.benzinga.com/general/health-care/24/12/42637278/eli-lillys-zepbound-receives-fda-approval-for-obesity-linked-sleep-apnea-drug" rel="noreferrer noopener">obstructive sleep apnea</a>.
Ongoing studies are exploring additional indications, such as reducing cardiovascular risks, addressing chronic kidney disease, and treating metabolic dysfunction-associated steatohepatitis (MASH).
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42600472/your-healthcare-costs-are-soaring-us-spending-reached-5-trillion-in-2023-with-major-increase-in-obesity-and-diabetes-drugs-hospital-services" rel="noreferrer noopener">Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services</a>.
GlobalData's Pharma Analyst, Costanza Alciati, highlighted that Eli Lilly is emulating Novo Nordisk's approach by exploring multiple therapeutic areas to broaden Zepbound's market potential.
Wegovy has been a game-changer in the obesity sector, earning widespread recognition and driving significant investment in the field. Over 400 companies are now developing obesity therapies inspired by Wegovy's success. The drug is also approved for managing type 2 diabetes and cardiovascular risks, with further research focusing on conditions like chronic kidney disease.
Despite Wegovy's achievements, Alciati remarked that Zepbound is "raising the bar" with greater potency and potential cost-effectiveness, making it a formidable contender in the obesity market.
In parallel, healthcare costs in the U.S. are climbing rapidly. Aon plc's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) August <a target="_blank" href="https://aon.mediaroom.com/2024-08-15-Aon-U-S-Employer-Health-Care-Costs-Projected-to-Increase-9-Percent-Next-Year" rel="noreferrer noopener">report</a> projects a 9% increase in employer-sponsored healthcare costs for 2025, exceeding $16,000 per employee.
This surge surpasses the 6.4% rise from 2023 to 2024, driven by higher medical claims, rising prescription drug expenses, and inflation-related adjustments.
Specialty drugs, particularly GLP-1 medications like tirzepatide and semaglutide, are key drivers of these rising costs. Aon's analysis reveals that these medications could add 1% to overall healthcare cost increases.
Despite their low utilization, these therapies significantly impact employer healthcare budgets.
On average, U.S. employers cover 81% of health plan costs, leaving employees to pay 19%, amounting to $4,858 annually, including premiums and out-of-pocket expenses.
In 2024, employer healthcare budgets grew by 6.4%, while employee premiums increased by a more modest 3.4%, according to Aon's analysis.
The technology and communications sector experienced the highest employer cost increase at 7.4% in 2024, while public sector employees faced the steepest rise in contributions at 6.7%.
In contrast, the healthcare industry saw no material change in employee contributions.
High-cost claims stemming from gene and cell therapies, complex medical procedures, and chronic conditions further strain employer budgets.
Price Action: LLY stock is up 0.88% at $778.79 during the premarket session at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/01/42763712/arcos-dorados-renews-franchise-agreement-with-mcdonalds-stock-gains" target="_blank" rel="noreferrer noopener">Arcos Dorados Renews Franchise Agreement With McDonald's, Stock Gains</a></li>
</ul>
Photo by Ciara Kimsey via Shutterstock

Biotech

Large Cap

Health Care

General

US Employer Health Costs To Rise In 2025 Fueled By Weight Loss: Report

Aon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) short percent of float has fallen 10.27% since its last report. The company recently reported that it has 4.29 million shares sold short, which is 2.01% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Aon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735587010_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Aon has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Aon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Aon's peer group average for short interest as a percentage of float is 3.02%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(AON) - Analyzing Aon's Short Interest

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 15 years by 4.16% on an annualized basis producing an average annual return of 15.8%. Currently, Aon has a market capitalization of $76.25 billion. 
Buying $1000 In AON: If an investor had bought $1000 of AON stock 15 years ago, it would be worth $9,117.66 today based on a price of $352.58 for AON at the time of writing.
<h3>Aon's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734557412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Aon Stock In The Last 15 Years

&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4323297-1&amp;h=2179076444&amp;u=https%3A%2F%2Fwww.aon.com%2F&amp;a=Aon+plc">Aon plc</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), a leading global professional services firm, and the European Bank for Reconstruction and Development (EBRD) have structured a tailor-made and highly innovative facility supporting the revitalization of the war risk insurance market in Ukraine. With support from Aon, the EBRD has launched a new guarantee designed to boost the provision of reinsurance capacity to private sector insurers, addressing the ongoing challenges posed by the war.
Under the new €110 million Ukraine Recovery and Reconstruction Guarantee Facility, the EBRD will support global reinsurance companies through a guarantee covering losses on specific war-related risks underwritten by local Ukrainian insurers. The structure seeks to leverage existing market infrastructure and tested risk transfer mechanisms from the insurance industry to provide the protection private sector investors require.&nbsp;

Aon and EBRD Launch €110M Facility to Revive Ukraine's War Risk Insurance Market

<a href="https://aon.mediaroom.com/2024-11-26-Aon-to-Acquire-In-House-Insurance-Agency-of-Mitsubishi-Chemical-Group-in-Japan">https://aon.mediaroom.com/2024-11-26-Aon-to-Acquire-In-House-Insurance-Agency-of-Mitsubishi-Chemical-Group-in-Japan</a>
&nbsp;
<a href="https://www.aon.com/">Aon plc</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), a leading global professional services firm, today announced the signing of a definitive agreement to acquire the in-house insurance agency business of Mitsubishi Chemical Group (MCG) enhancing Aon's risk and health capability offering in Japan.
The in-house insurance agency operates as part of Dia Rix, an in-house business services provider to MCG. Aon will acquire the insurance agency business which provides corporate and personal lines insurance to MCG group companies and employees in Japan. The divestiture will allow MCG to divert resources and investment to its core business while leveraging the global risk management capabilities of Aon to strengthen its global governance.
Following the close of the transaction, the team will transition to Aon's brand and operating model, under the leadership of Tatsuya Yamamoto, head of Aon in Japan, bringing together a combined team of more than 400 colleagues.
Anne Corona, CEO for Aon in Asia Pacific said: "This acquisition reinforces our investment in Japan as an important market for Aon. The existing synergies we share with Dia Rix in terms of capability and culture will allow us to better serve MCG as well as strengthen broader capability and development opportunities for colleagues at the combined firm."
Tatsuya Yamamoto added: "The current changes in the non-life insurance environment in Japan will foster an environment in which global companies like the MCG can focus on their core business by divesting their in-house insurance agency operations, while at the same time supporting their operational efficiency strategies and leveraging a group of experts like Aon to provide an opportunity for more sophisticated global risk management. We are well situated to take this business forward building on our existing capabilities and growth momentum and continue to provide optimal solutions for all our clients in Japan."
The firms will continue to operate independently until the transaction is completed, which is expected in early 2025.

Global

Aon To Acquire In-House Insurance Agency Of Mitsubishi Chemical Group In Japan; No Financial Terms Disclosed

Barclays analyst Alex Scott maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Overweight and raises the price target from $394 to $440.

Barclays Maintains Overweight on Aon, Raises Price Target to $440

BMO Capital analyst Michael Zaremski maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Market Perform and raises the price target from $325 to $380.

BMO Capital Maintains Market Perform on Aon, Raises Price Target to $380

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4292490-1&amp;h=325971108&amp;u=https%3A%2F%2Fwww.aon.com%2Fen%2F&amp;a=Aon+plc">Aon plc</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), a leading global professional services firm, today announced the signing of a definitive agreement to acquire UK-based insurance broker Griffiths &amp; Armour. Upon completion of the transaction, Griffiths &amp; Armour will become wholly-owned by Aon UK Limited and is proposed to go to market as "Griffiths &amp; Armour, an Aon company".
The acquisition closely aligns with Aon's strategy to further expand its presence in the UK and Ireland. The combination will provide a greater breadth of solutions for clients across both Aon and Griffiths &amp; Armour with complementary strengths that create a platform for further growth in the UK, Ireland and beyond. Together, Aon and Griffiths &amp; Armour share a strong cultural alignment through an unwavering focus on clients and colleagues.

Aon To Acquire UK-Based Insurance Broker Griffiths & Armour; Financial Terms Not Disclosed

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) has outperformed the market over the past 10 years by 4.29% on an annualized basis producing an average annual return of 15.51%. Currently, Aon has a market capitalization of $80.39 billion. 
Buying $1000 In AON: If an investor had bought $1000 of AON stock 10 years ago, it would be worth $4,290.38 today based on a price of $371.71 for AON at the time of writing.
<h3>Aon's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730223012_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Aon 10 Years Ago Would Be Worth This Much Today

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) with a Outperform and raises the price target from $385 to $415.

Keefe, Bruyette & Woods Maintains Outperform on Aon, Raises Price Target to $415

<a href="https://www.insuranceinsider.com/?zephr_sso_ott=Ws3rp8">https://www.insuranceinsider.com/?zephr_sso_ott=Ws3rp8</a>
&nbsp;

'Aon In Advanced Talks To Acquire ~£350 Million Griffiths & Armour' - Insurance Insider

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58933b2143eaaa0001698f54/meta-marshall">Morgan Stanley analyst Meta Marshall</a> upgraded the rating for Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) from Equal-Weight to Overweight and raised the price target from $71 to $72. Nutanix shares closed at $61.59 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Macquarie analyst Eugene Hsiao upgraded NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) from Neutral to Outperform and announced a $6.6 price target. NIO shares closed at $5.26 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59f71cb5efacff0001835807/elyse-greenspan">Wells Fargo analyst Elyse Greenspan </a>upgraded Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) from Underweight to Equal-Weight and raised the price target from $315 to $377. AON shares closed at $375.44 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Nigel Coe upgraded the rating for Dover Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) from Peer Perform to Outperform and announced a $227 price target. Dover shares closed at $186.98 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Melius Research analyst Conor Cunningham upgraded Alaska Air Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) from Hold to Buy and announced a $56 price target. Alaska Air shares closed at $45.54 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NIO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28094222/image-278-1024x586.png" alt="" class="wp-image-617166" style="width:612px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28094222/image-278-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28094222/image-278-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28094222/image-278-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28094222/image-278.png 1086w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a></li>
</ul>

Upgrades

Markets

NTNX

This Nio Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Wells Fargo analyst Elyse Greenspan upgrades Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) from Underweight to Equal-Weight and raises the price target from $315 to $377.

Wells Fargo Upgrades Aon to Equal-Weight, Raises Price Target to $377

Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week&#8217;s pivotal earnings releases from <a href="https://www.benzinga.com/topic/magnificent-7">five of the &#8220;Magnificent Seven&#8221; stocks.</a>
Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>), Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) will all report quarterly earnings between Oct. 29 and Oct. 31.
Combined, nearly 45% of the S&amp;P 500 by market cap is set to report results next week, with other heavyweights including McDonald&#8217;s Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), Mastercard Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) and Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>).
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) continued its upward trajectory on Friday, rising 2.7% following a massive 21% jump on Thursday — its biggest one-day gain since May 2013.
The S&amp;P 500 was up 0.5% at midday trading in New York, while the Nasdaq 100 surged by 1.5%, fueled by semiconductor stocks. 
The Dow Jones Industrial Average fell 0.3%, on track to end a six-week winning streak. The U.S. dollar strengthened further, with the DXY Index rising past the 104 mark, setting up for a fourth straight week of gains. Meanwhile, Treasury yields were steady. 
WTI crude rose 1.8%, driven by concerns over geopolitical tensions in the Middle East. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is up slightly at $67,695.
<h1 class="wp-block-heading">Friday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % change</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,500.56</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,839.28</td>
<td>0.5%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,219.60</td>
<td>0.3%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,271.11</td>
<td>-0.3%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:50 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102225&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.5% to $582.19.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 0.2% to $423.18.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rallied 1.3% to $498.83.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.2% up to $220.09.</li>
<li>The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up by 1.4%. The Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged, down 0.9%.</li>
</ul>
<h1 class="wp-block-heading">Thursday&#8217;s Stock Movers</h1>
<ul>
<li>Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) rallied 7% to levels last seen in October 2021 on better-than-expected quarterly results. </li>
<li>Digital Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) rallied over 10% after reporting record new lease bookings. </li>
</ul>
Other stocks reacting to earnings included:
<ul>
<li>Ameriprise Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>), down 0.13%</li>
<li>DexCom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>), down 1%</li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) up 7.6%, </li>
<li>Skechers U.S.A. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) down 0.2%, </li>
<li>Western Digital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) up 7.6%, </li>
<li>Deckers Outdoor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>), up 11%</li>
<li>Edward Lifesciences Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>), down by 0.6%</li>
<li>HCA Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), down 10%, </li>
<li>Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>), up 6%, </li>
<li>Colgate-Palmolive Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>), down 3.4%, </li>
<li>Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>), up 6.7%, </li>
<li>Saia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>), up 9.2%. </li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41549147/goldman-sachs-analyst-remains-bullish-on-boeing-despite-weak-q3-long-term-deep-valu">Goldman Sachs Analyst Remains Bullish On Boeing Despite Weak Q3: &#8216;Long-Term Deep-Value Opportunity</a>&#8216;</li>
</ul>
Photo: Shutterstock

Earnings

Equities

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

AAPL

AMZN

DECK

SPDR Dow Jones Industrial Average ETF Trust

DXCM

GOOG

GOOGL

MSFT

RIVN

SAIA

TSLA

Select Sector SPDR-Consumer Discretionary

Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?

WIIM

Aon shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

Guidance

Aon Says Performance Through First Three Quarters Positions It Well To Deliver Full Year Results In Line With Financial Guidance

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) reported quarterly earnings of $2.72 per share which beat the analyst consensus estimate of $2.48 by 9.68 percent. This is a 17.24 percent increase over earnings of $2.32 per share from the same period last year. The company reported quarterly sales of $3.72 billion which beat the analyst consensus estimate of $3.69 billion by 0.73 percent. This is a 26.01 percent increase over sales of $2.95 billion the same period last year.

Earnings Beats

Aon Q3 2024 Adj EPS $2.72 Beats $2.48 Estimate, Sales $3.72B Beat $3.69B Estimate

Aon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) is set to give its latest quarterly earnings report on Friday, 2024-10-25. Here's what investors need to know before the announcement.
Analysts estimate that Aon will report an earnings per share (EPS) of $2.48. 
The market awaits Aon's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company missed EPS by $0.15, leading to a 0.0% drop in the share price the following trading session.
Here's a look at Aon's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>3.08</td>
<td>5.91</td>
<td>4.06</td>
<td>2.21</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.93</td>
<td>5.66</td>
<td>3.89</td>
<td>2.32</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>-7.000000000000001%</td>
<td>-3.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729782036_0.png" alt="eps graph" />
<h3>Market Performance of Aon's Stock</h3>
Shares of Aon were trading at $358.29 as of October 23. Over the last 52-week period, shares are up 16.82%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Observations about Aon</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Aon.
The consensus rating for Aon is Neutral, based on 11 analyst ratings. With an average one-year price target of $351.91, there's a potential 1.78% downside.
<h3>Comparing Ratings with Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Arthur J. Gallagher, Marsh &amp; McLennan and Brown &amp; Brown, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>The consensus outlook from analysts is an Neutral trajectory for Arthur J. Gallagher, with an average 1-year price target of $289.4, indicating a potential 19.23% downside.</li>
<li>For Marsh &amp; McLennan, analysts project an Neutral trajectory, with an average 1-year price target of $233.8, indicating a potential 34.75% downside.</li>
<li>The consensus outlook from analysts is an Neutral trajectory for Brown &amp; Brown, with an average 1-year price target of $110.38, indicating a potential 69.19% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary outlines pivotal metrics for Arthur J. Gallagher, Marsh &amp; McLennan and Brown &amp; Brown, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aon</td>
<td>Neutral</td>
<td>18.35%</td>
<td>$1.63B</td>
<td>18.30%</td>
</tr>
<tr>
<td>Arthur J. Gallagher</td>
<td>Neutral</td>
<td>13.66%</td>
<td>$1.12B</td>
<td>2.48%</td>
</tr>
<tr>
<td>Marsh &amp; McLennan</td>
<td>Neutral</td>
<td>5.85%</td>
<td>$2.25B</td>
<td>5.52%</td>
</tr>
<tr>
<td>Brown &amp; Brown</td>
<td>Neutral</td>
<td>11.39%</td>
<td>$569M</td>
<td>4.30%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Aon ranks at the top for Revenue Growth among its peers, with the highest percentage at 18.35%. In terms of Gross Profit, Aon is also leading with $1.63B. However, Aon's Return on Equity is slightly lower compared to its peers, standing at 18.30%. Overall, Aon is positioned favorably compared to its peers in this analysis.
<h3>Discovering Aon: A Closer Look</h3>
Aon is a leading global provider of insurance and reinsurance brokerage and human resources solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in over 120 countries.
<h3>Unraveling the Financial Story of Aon</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Aon's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 18.35%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Aon's net margin excels beyond industry benchmarks, reaching 13.94%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Aon's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 18.3%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.14%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 3.16, Aon faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/AON/earnings">To track all earnings releases for Aon visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For Aon

Barclays raised the firm's price target on Aon plc (AON) to $440 from $394 and keeps an Overweight rating on the shares. The firm updated organic g...

Aon plc price target raised to $440 from $394 at Barclays

Diamond Hill Large Cap Strategy Fund Q3 2024 Market Commentary

Diamond Hill Large Cap Concentrated Strategy Fund Q3 2024 Market Commentary

Aon names Anne Corona as CEO of Enterprise Clients

Jefferies raised the firm's price target on Aon plc (AON) to $400 from $396 and keeps a Hold rating on the shares. The firm's preference into 2025 ...

Aon plc price target raised to $400 from $396 at Jefferies

Lazard International Quality Growth Portfolio Q3 2024 Commentary

Lazard International Strategic Equity Portfolio Q3 2024 Commentary

JPMorgan raised the firm's price target on Aon plc (AON) to $394 from $379 and keeps an Overweight rating on the shares. The analyst remains upbeat...

Aon plc price target raised to $394 from $379 at JPMorgan

In a report released today, Alex Scott from Barclays maintained a Buy rating on Aon (AON – Research Report), with a price target of $440.00. The co...

Aon (AON) Receives a Buy from Barclays

Aon plc: Better Position Than Before, But Some Distance Before A 'Buy'

ASML

ASMLF

BLDR

BLMIF

CLCGY

DHIL

FANG

ICLR

NONOF

SBAC

SHMZF

SNROF

UMGNF

UNLYF

UNVGY

VACNY

VTTGF

Press Releases

Canadian Employer Medical Costs to Spike 7.4 Percent in 2025: Aon Report

Insurance

Aon Launches Cyber Risk Analyzer to Mitigate Clients' Cyber Risk Exposure

Jeeno Thitikul Wins $1 Million Prize in 2024 Aon Risk Reward Challenge

Aon Client Treaty Renews with Record-Setting Support for 2025

Aon names Anne Corona as CEO of Enterprise Clients and Global Chief Commercial Officer

Seventy-Five Percent of U.S. Employers Are Unprepared for Pay Transparency Laws, Aon Reports

U.S. Hospitals Report Lower Clinician Turnover, Aon Reports

Fintech

Aon and the European Bank for Reconstruction and Development launch innovative war risk insurance facility for Ukraine

WOODWARD PARK PARTNERS ADVISES SALUS GROUP IN ITS SALE TO NFP, A WHOLLY OWNED SUBSIDIARY OF AON

Canadian defined benefit pension plans show slightly decreased funded levels in Q4: Aon

Abacus Life

Arthur J. Gallagher

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Health In Tech, Inc. - Class A Common Stock

Health In Tech

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Reliance Global Group, Inc. - Common Stock

Reliance Global Group

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

SelectQuote

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

Aon

ニュース

最新ニュース Aon (NYSE:AON) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル